GENERAL ENQUIRIES: Tel: + 27 12 841 2911 | Email: callcentre@csir.co.za

Show simple item record

dc.contributor.author Bode, M
dc.contributor.author Gledhill, Irvy MA
dc.contributor.author Gravestock, D
dc.contributor.author Hoppe, H
dc.contributor.author Khan, T
dc.contributor.author Moleele, S
dc.contributor.author Nkabinde, L
dc.contributor.author Pelly, S
dc.contributor.author van der Westhuyzen, C
dc.date.accessioned 2010-09-28T08:07:04Z
dc.date.available 2010-09-28T08:07:04Z
dc.date.issued 2010-09
dc.identifier.citation Bode, M, Gledhill, I, Gravestock, D, Hoppe, H et al. 2010. Compounds acting against HIV: Imidazo[1,2-a]pyridines as non-nucleoside reverse transcriptase inhibitors (NNRTIs). NNRTI presentation CSIR conference 2010, pp 16 en
dc.identifier.uri http://hdl.handle.net/10204/4369
dc.description NNRTI presentation CSIR conference 2010 en
dc.description.abstract A compound possessing anti-HIV activity similar to that of FDA-approved nevirapine was developed. It acts as a non-nucleoside reverse transcriptase inhibitor, the compound shows good cell permeability, and a quantitative structure activity relationship (QSAR) was developed for the compound series. en
dc.language.iso en en
dc.publisher CSIR en
dc.subject Anti-HIV activity en
dc.subject Nevirapine en
dc.subject Non-nucleoside reverse transcriptase inhibitors en
dc.subject NNRTIs en
dc.subject Imidazo[1,2-a]pyridines en
dc.title Compounds acting against HIV: Imidazo[1,2-a]pyridines as non-nucleoside reverse transcriptase inhibitors (NNRTIs) en
dc.type Presentation en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ResearchSpace


Advanced Search

Browse

My Account